home / stock / chyhy / chyhy news


CHYHY News and Press, CHR Hansen Holding A/S ADR From 07/06/23

Stock Information

Company Name: CHR Hansen Holding A/S ADR
Stock Symbol: CHYHY
Market: OTC

Menu

CHYHY CHYHY Quote CHYHY Short CHYHY News CHYHY Articles CHYHY Message Board
Get CHYHY Alerts

News, Short Squeeze, Breakout and More Instantly...

CHYHY - Chr. Hansen GAAP EPS of ?0.45, revenue of ?355M

2023-07-06 14:29:43 ET Chr. Hansen Press release ( OTCPK:CHYHY ): Q3 GAAP EPS of Є0.45. Revenue of Є355M (+11.6% Y/Y). For further details see: Chr. Hansen GAAP EPS of Є0.45, revenue of Є355M

CHYHY - Chr. Hansen Holding A/S (CHYHY) Q3 2022 Earnings Call Transcript

2023-07-06 11:59:06 ET Chr. Hansen Holding A/S (CHYHY) Q3 2022 Earnings Conference Call July 06, 2023, 4:00 AM ET Company Participants Mauricio Graber - President and Chief Executive Officer Lise Mortensen - Executive Vice President and Chief Financial Officer ...

CHYHY - Novozymes And Christian Hansen: A Danish Merger (Rating Upgrade)

2023-06-02 05:36:23 ET Summary Danish companies Novozymes and Christian Hansen have announced plans to merge, creating a leading global biosolutions company. The merger is expected to be completed in late 2023 or early 2024, following regulatory approval. Despite the wide econ...

CHYHY - Novozymes: Wonderful Company, Almost Reasonable Price

Summary Novozymes is a Danish company that produces industrial enzymes, often used to replace chemicals in products and industrial processes. The company's products have a wide range of applications in household care, food and beverage, bio-energy, agriculture, feed, and even pharmaceut...

CHYHY - RPM International: The Future's Looking Up, But Shares Are Still Not Right

RPM International had an interesting fiscal year that it just reported financial results for. RPM's sales continued to climb, but some profitability metrics could have been better. The future is looking brighter, but there is some uncertainty about what the picture looks like beyo...

CHYHY - Seres Therapeutics: The Good And The Challenging

Seres' $100 million share placement with strategic partners, including Nestle, helps stabilize the share price. The C. difficile market - how big is it? Who can compete with the Seres/Nestle (Aimmune Therapeutics) global rollout for C. difficile recurrence? Seres has had two share...

CHYHY - Chr. Hansen Is A Truly Amazing Company With Significant Pricing Power

Chr. Hansen has a wide competitive moat that allows it to earn good profit margins and maintain significant pricing power. The company operates in several attractive markets and has the potential to grow at a decent pace. Unfortunately, the valuation remains high, even despite a r...

CHYHY - Chr. Hansen: A Great Business, But Unfortunately Still Overvalued

Chr. Hansen is a great business and has a wide economic moat around its business. In the last few years, Chr. Hansen was rather struggling. Despite the share price dropping, it is still overvalued in my opinion. For further details see: Chr. Hansen: A Great Business, But...

CHYHY - Chr. Hansen Holding A/S (CHYHY) CEO Mauricio Graber on Q2 2022 Results - Earnings Call Transcript

Chr. Hansen Holding A/S (CHYHY) Q2 2022 Earnings Conference Call April 6 2022, 04:00 AM ET Company Participants Mauricio Graber - President and CEO Lise Mortensen - CFO Conference Call Participants Alexander Sloane - Barclays Christian Ryom - Nordea Markets Soren Samsoe - SEB Lars Topholm - C...

CHYHY - Chr. Hansen Holding A/S 2022 Q2 - Results - Earnings Call Presentation

The following slide deck was published by Chr. Hansen Holding A/S in conjunction with their 2022 Q2 earnings call. For further details see: Chr. Hansen Holding A/S 2022 Q2 - Results - Earnings Call Presentation

Previous 10 Next 10